Loading...
Loading...
Among the 1 tracked institutional investors we monitor, APUS (APIMEDS PHARMACEUTICALS US I) is held with a combined value of $96.75K across 58,992 shares. The largest holder is VANGUARD GROUP INC with a position worth $96.75K (0.00% of their portfolio). VANGUARD GROUP INC opened a new position in the most recent quarter.
Total Institutional Value
$96.75K
Total Shares Held
58,992
Institutional Holders
1
| # | Fund | Value↓ | Portfolio % | Change |
|---|---|---|---|---|
| 1 | VANGUARD GROUP INC | $96.75K | 0.00% | New |
As of the latest SEC 13F filings, VANGUARD GROUP INC is the largest institutional holder of APUS with a position worth $96.75K, representing 0.00% of their portfolio. In total, 1 institutional investors hold APUS with a combined value of $96.75K.
In the most recent quarter, 1 fund opened a new position in APUS.
Institutional investors hold $96.75K worth of APUS stock across 1 positions. The largest institutional holder is VANGUARD GROUP INC with $96.75K in holdings.
A 13F filing is a quarterly report required by the SEC from institutional investment managers with over $100 million in assets. It discloses their holdings in U.S. equities. For APUS, these filings reveal which major funds are accumulating or reducing positions, providing insights into institutional sentiment.
Get notified when hedge funds change their APUS positions.